Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the combination of bevacizumab and pemetrexed
have an effect on recurrent ovarian and primary peritoneal carcinoma by looking at
progression and survival at 6 months.